{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:19:59Z","timestamp":1790266799267,"version":"4.1.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Pituitary apoplexy (PA) is a rare, and potentially life-threatening condition, caused by hemorrhage or infarction into the pituitary gland with a rapid expansion of the contents of the sella turcica, associated with sudden intense headache, neurological and endocrinological deterioration. The identification of risk factors is crucial for prevention and optimal management. Herein we report a case of PA occurring 1 month after the initiation of anabolic androgenic steroid abuse for bodybuilding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Report<\/jats:title><jats:p>A 40-year-old male patient presents with abrupt onset headache associated with left partial third cranial nerve palsy. The MRI shows a sellar lesion involving left cavernous sinus with a heterogenous anterior aspect of the lesion with hemorrhagic zones in favor of PA. Endocrine work-up shows high testosterone level in patient who was using exogenous testosterone without a medical prescription for a month.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We report a case of PA of a pituitary neuroendocrine tumor occurring shortly after AAS. The association between PA and AAS should be considered as a potential risk.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.890853","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T13:13:00Z","timestamp":1658495580000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Potential Association Between Anabolic Androgenic Steroid Abuse and Pituitary Apoplexy: A Case Report"],"prefix":"10.3389","volume":"13","author":[{"given":"Agne","family":"Andriuskeviciute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Ameti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy Thomas","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Messerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary Apoplexy","volume":"36","author":"Briet","year":"2015","journal-title":"Endocr Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-009-0595-8","article-title":"Pituitary Apoplexy: An Overview of 186 Cases Published During the Last Century","volume":"152","author":"Turgut","year":"2010","journal-title":"Acta Neurochirurgica"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0255","article-title":"Clinical and Biochemical Characteristics of Patients Presenting With Pituitary Apoplexy","volume":"7","author":"Abbara","year":"2018","journal-title":"Endocr Connections"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2019.06.001","article-title":"Pituitary Apoplexy","volume":"30","author":"Barkhoudarian","year":"2019","journal-title":"Neurosurg Clinics North A"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8625","article-title":"An Exceptional Presentation of Pituicytoma Apoplexy: A Case Report","volume":"16","author":"Cossu","year":"2018","journal-title":"Oncol Lett"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-005-1050-3","article-title":"Pituitary Apoplexy: A Review of Clinical Presentation, Management and Outcome in 45 Cases","volume":"7","author":"Sibal","year":"2004","journal-title":"Pituitary"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.488","article-title":"A Case of Pituitary Apoplexy Masquerading as Subarachnoid Hemorrhage","volume":"4","author":"Choudhury","year":"2016","journal-title":"Clin Case Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.46.594","article-title":"Pituitary Apoplexy Manifesting as Diffuse Subarachnoid Hemorrhage","volume":"46","author":"Nakahara","year":"2006","journal-title":"Neurol Medico Chirurgica"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2016.07.013","article-title":"Ischemic Pituitary Adenoma Apoplexy\u2014Clinical Appearance and Prognosis After Surgical Intervention","volume":"148","author":"Ogawa","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-010-0706-6","article-title":"Apoplexy in Pituitary Microadenomas","volume":"152","author":"Randall","year":"2010","journal-title":"Acta Neurochirurgica"},{"key":"B11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clineuro.2006.01.006","article-title":"Classical Pituitary Tumour Apoplexy: Clinical Features, Management and Outcomes in a Series of 24 Patients","volume":"109","author":"Dubuisson","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1530\/EJE-10-0651","article-title":"Pituitary Apoplexy: Re-Evaluation of Risk Factors for Bleeding Into Pituitary Adenomas and Impact on Outcome","volume":"164","author":"M\u00f6ller-Goede","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/endrev\/bnab001","article-title":"Androgen Misuse and Abuse","volume":"42","author":"Handelsman","year":"2021","journal-title":"Endocr Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The Global Epidemiology of Anabolic-Androgenic Steroid Use: A Meta-Analysis and Meta-Regression Analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02734.x","article-title":"Anabolic-Androgenic Steroid Dependence: An Emerging Disorder","volume":"104","author":"Kanayama","year":"2009","journal-title":"Addiction"},{"key":"B16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.JNS141083","article-title":"Invasion of the Cavernous Sinus Space in Pituitary Adenomas: Endoscopic Verification and Its Correlation With an MRI-Based Classification","volume":"122","author":"Micko","year":"2015","journal-title":"J Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.09.047","article-title":"Surgical Versus Non-Surgical Treatment for Pituitary Apoplexy: A Systematic Review and Meta-Analysis","volume":"370","author":"Tu","year":"2016","journal-title":"J Neurol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2011.1.FOCUS10308","article-title":"Evidence of Improved Surgical Outcome Following Endoscopy for Nonfunctioning Pituitary Adenoma Removal","volume":"30","author":"Messerer","year":"2011","journal-title":"Neurosurg Focus"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2013.02.027","article-title":"Pituitary Apoplexy Associated With Cabergoline Therapy","volume":"20","author":"Chng","year":"2013","journal-title":"J Clin Neurosci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"160021","DOI":"10.1530\/EDM-16-0021","article-title":"Gonadotropin-Releasing Hormone Agonist-Induced Pituitary Apoplexy","volume":"2016","author":"Keane","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0211-4","article-title":"Testosterone Replacement Therapy and Cardiovascular Risk","volume":"16","author":"Gagliano-Juc\u00e1","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2012.4","article-title":"Hormonal Effects on Blood Vessels","volume":"35","author":"Akishita","year":"2012","journal-title":"Hypertension Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.amjmed.2019.03.022","article-title":"Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men With Low Testosterone Levels: A Cohort Study","volume":"132","author":"Loo","year":"2019","journal-title":"Am J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.11.2742","article-title":"Testosterone Increases Human Platelet Thromboxane A 2 Receptor Density and Aggregation Responses","volume":"91","author":"Ajayi","year":"1995","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/15376516.2017.1351015","article-title":"Pretreatment of Different Biological Matrices for Exogenous Testosterone Analysis: A Review","volume":"27","author":"Pizzato","year":"2017","journal-title":"Toxicol Mech Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use","volume":"135","author":"Baggish","year":"2017","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-79088-4_18","article-title":"Androgenic Anabolic Steroid Abuse and the Cardiovascular System","volume":"195","author":"Vanberg","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamainternmed.2015.1573","article-title":"Comparative Safety of Testosterone Dosage Forms","volume":"175","author":"Layton","year":"2015","journal-title":"JAMA Internal Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13574","article-title":"Injection Testosterone and Adverse Cardiovascular Events: A Case-Crossover Analysis","volume":"88","author":"Layton","year":"2018","journal-title":"Clin Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000088660.16904.F7","article-title":"Clinical Characteristics of Silent Corticotrophic Adenomas and Creation of An Internet-Accessible Database to Facilitate Their Multi-Institutional Study","volume":"53","author":"Webb","year":"2003","journal-title":"Neurosurgery"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01133-8","article-title":"Clinical Profiles of Silent Corticotroph Adenomas Compared With Silent Gonadotroph Adenomas After Adopting the 2017 WHO Pituitary Classification System","volume":"24","author":"Jiang","year":"2021","journal-title":"Pituitary"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.890853\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T13:13:03Z","timestamp":1658495583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.890853\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":33,"alternative-id":["10.3389\/fendo.2022.890853"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.890853","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"article-number":"890853"}}